These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 38837956

  • 21. Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.
    Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.
    Surg Today; 2013 Sep; 43(9):1039-48. PubMed ID: 23467980
    [Abstract] [Full Text] [Related]

  • 22. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 23. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS, Goja S, Yadav SK, Tamang TY, Rastogi A, Bhangui P, Thiagrajan S, Raut V, Babu RY, Saigal S, Saraf N, Choudhary NS, Vohara V.
    Clin Transplant; 2017 May 01; 31(5):. PubMed ID: 28239914
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.
    Transplantation; 2024 Mar 01; 108(3):713-723. PubMed ID: 37635282
    [Abstract] [Full Text] [Related]

  • 26. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM.
    Ann Surg Oncol; 2019 May 01; 26(5):1454-1462. PubMed ID: 30737669
    [Abstract] [Full Text] [Related]

  • 27. Results of pediatric living donor compared to deceased donor liver transplantation in the PELD/MELD era: Experience from two centers on two different continents.
    Yankol Y, Fernandez LA, Kanmaz T, Leverson GE, Mezrich JD, Foley D, Mecit N, D'Alessandro AM, Acarli K, Kalayoglu M.
    Pediatr Transplant; 2016 Feb 01; 20(1):72-82. PubMed ID: 26861217
    [Abstract] [Full Text] [Related]

  • 28. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y, Wang Q, Yang J, Yan L.
    PLoS One; 2015 Feb 01; 10(9):e0136604. PubMed ID: 26378786
    [Abstract] [Full Text] [Related]

  • 29. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S.
    Prog Transplant; 2018 Sep 01; 28(3):213-219. PubMed ID: 29902957
    [Abstract] [Full Text] [Related]

  • 30. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.
    Transplant Proc; 2016 May 01; 48(4):1025-31. PubMed ID: 27320548
    [Abstract] [Full Text] [Related]

  • 31. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A, Ganesh S, Jorgensen D, Tevar A, Ganoza A, Molinari M, Hughes C.
    Ann Surg; 2019 Sep 01; 270(3):444-451. PubMed ID: 31305283
    [Abstract] [Full Text] [Related]

  • 32. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, Bhangui P, Soin AS.
    Clin Transplant; 2017 Aug 01; 31(8):. PubMed ID: 28497523
    [Abstract] [Full Text] [Related]

  • 33. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.
    Liver Transpl; 2013 Mar 01; 19(3):259-67. PubMed ID: 23495079
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, A2ALL Study Group.
    Am J Transplant; 2012 Nov 01; 12(11):2997-3007. PubMed ID: 22994906
    [Abstract] [Full Text] [Related]

  • 36. Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation.
    Saidi RF, Jabbour N, Li Y, Shah SA, Bozorgzadeh A.
    HPB (Oxford); 2011 Nov 01; 13(11):797-801. PubMed ID: 21999593
    [Abstract] [Full Text] [Related]

  • 37. Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study).
    Jayant K, Cotter TG, Reccia I, Virdis F, Podda M, Machairas N, Arasaradnam RP, Sabato DD, LaMattina JC, Barth RN, Witkowski P, Fung JJ.
    J Clin Med; 2023 Sep 06; 12(18):. PubMed ID: 37762738
    [Abstract] [Full Text] [Related]

  • 38. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y.
    Liver Transpl; 2016 Dec 06; 22(12):1666-1675. PubMed ID: 27540888
    [Abstract] [Full Text] [Related]

  • 39. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 06; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 40. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
    Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL, A2ALL Study Group.
    Am J Transplant; 2007 Jun 06; 7(6):1601-8. PubMed ID: 17511683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.